Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second‐line clinical trials

BACKGROUND: Intrahepatic cholangiocarcinoma (iCCA) is the second most frequent liver cancer. The overall survival of iCCA and other biliary tract cancers (BTC) remains poor. Recently, the ABC‐06 trial reported the superiority of FOLFOX vs clinical observation as a second‐line treatment. Still, the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Tovoli, Francesco, Garajová, Ingrid, Gelsomino, Fabio, Iavarone, Massimo, Federico, Piera, Salati, Massimiliano, Corianò, Matilde, Caputo, Francesco, De Lorenzo, Stefania, Granito, Alessandro, Renzulli, Matteo, Daniele, Bruno, Piscaglia, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Liver Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300150/
https://www.ncbi.nlm.nih.gov/pubmed/34826193
http://dx.doi.org/10.1111/liv.15117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300150/
https://www.ncbi.nlm.nih.gov/pubmed/34826193
http://dx.doi.org/10.1111/liv.15117

Ejemplares similares